These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8945617)

  • 1. Methylated CpG points identified within MAGE-1 promoter are involved in gene repression.
    Serrano A; García A; Abril E; Garrido F; Ruiz-Cabello F
    Int J Cancer; 1996 Nov; 68(4):464-70. PubMed ID: 8945617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2'-deoxycytidine.
    Sigalotti L; Fratta E; Coral S; Tanzarella S; Danielli R; Colizzi F; Fonsatti E; Traversari C; Altomonte M; Maio M
    Cancer Res; 2004 Dec; 64(24):9167-71. PubMed ID: 15604288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter.
    De Smet C; Lurquin C; Lethé B; Martelange V; Boon T
    Mol Cell Biol; 1999 Nov; 19(11):7327-35. PubMed ID: 10523621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine.
    Weber J; Salgaller M; Samid D; Johnson B; Herlyn M; Lassam N; Treisman J; Rosenberg SA
    Cancer Res; 1994 Apr; 54(7):1766-71. PubMed ID: 7511051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.
    De Smet C; De Backer O; Faraoni I; Lurquin C; Brasseur F; Boon T
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7149-53. PubMed ID: 8692960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription of the MAGE-1 gene and the methylation status of its Ets binding promoter elements: a quantitative analysis in melanoma cell lines using a real-time polymerase chain reaction technique.
    Janssen BL; van de Locht LT; Fourkour A; de Smet C; Mensink EJ; van Muijen GN; de Vries TJ
    Melanoma Res; 1999 Jun; 9(3):213-22. PubMed ID: 10465576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
    Wischnewski F; Friese O; Pantel K; Schwarzenbach H
    Mol Cancer Res; 2007 Jul; 5(7):749-59. PubMed ID: 17634428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter-dependent mechanism leading to selective hypomethylation within the 5' region of gene MAGE-A1 in tumor cells.
    De Smet C; Loriot A; Boon T
    Mol Cell Biol; 2004 Jun; 24(11):4781-90. PubMed ID: 15143172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells.
    Wischnewski F; Pantel K; Schwarzenbach H
    Mol Cancer Res; 2006 May; 4(5):339-49. PubMed ID: 16687489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression spectrum and methylation-dependent regulation of melanoma antigen-encoding gene family members in pancreatic cancer cells.
    Bert T; Lubomierski N; Gangsauge S; Münch K; Printz H; Prasnikar N; Robbel C; Simon B
    Pancreatology; 2002; 2(2):146-54. PubMed ID: 12123095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells.
    Liu G; Ying H; Zeng G; Wheeler CJ; Black KL; Yu JS
    Cancer Res; 2004 Jul; 64(14):4980-6. PubMed ID: 15256472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes.
    Vatolin S; Abdullaev Z; Pack SD; Flanagan PT; Custer M; Loukinov DI; Pugacheva E; Hong JA; Morse H; Schrump DS; Risinger JI; Barrett JC; Lobanenkov VV
    Cancer Res; 2005 Sep; 65(17):7751-62. PubMed ID: 16140943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of the neutral endopeptidase gene promoter in human prostate cancers.
    Usmani BA; Shen R; Janeczko M; Papandreou CN; Lee WH; Nelson WG; Nelson JB; Nanus DM
    Clin Cancer Res; 2000 May; 6(5):1664-70. PubMed ID: 10815884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MAGE-A1 gene expression is not determined solely by methylation status of the promoter region in hematological malignancies.
    Suyama T; Ohashi H; Nagai H; Hatano S; Asano H; Murate T; Saito H; Kinoshita T
    Leuk Res; 2002 Dec; 26(12):1113-8. PubMed ID: 12443884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited gene activation in tumor and normal epithelial cells treated with the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine.
    Karpf AR; Lasek AW; Ririe TO; Hanks AN; Grossman D; Jones DA
    Mol Pharmacol; 2004 Jan; 65(1):18-27. PubMed ID: 14722233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel member of the snail/Gfi-1 repressor family, mlt 1, which is methylated and silenced in liver tumors of SV40 T antigen transgenic mice.
    Tateno M; Fukunishi Y; Komatsu S; Okazaki Y; Kawai J; Shibata K; Itoh M; Muramatsu M; Held WA; Hayashizaki Y
    Cancer Res; 2001 Feb; 61(3):1144-53. PubMed ID: 11221845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of BAGE, GAGE, and MAGE genes in human gastric carcinoma.
    Li J; Yang Y; Fujie T; Baba K; Ueo H; Mori M; Akiyoshi T
    Clin Cancer Res; 1996 Sep; 2(9):1619-25. PubMed ID: 9816341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
    Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter methylation controls the expression of MAGE2, 3 and 4 genes in human cutaneous melanoma.
    Sigalotti L; Coral S; Nardi G; Spessotto A; Cortini E; Cattarossi I; Colizzi F; Altomonte M; Maio M
    J Immunother; 2002; 25(1):16-26. PubMed ID: 11924907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.